Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Stemcell Holdings Cash from Investing (Quarterly): -0.1868M for Sept. 30, 2018
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | -0.1868M |
| June 30, 2018 | -0.1875M |
| March 31, 2018 | -0.6808M |
| December 31, 2017 | -0.1075M |
| September 30, 2017 | -0.2273M |
| June 30, 2017 | -0.1566M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.1886M |
| December 31, 2016 | -0.2077M |
| September 30, 2016 | -0.3738M |
| June 30, 2016 | -0.0016M |
| March 31, 2016 | -0.0178M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -0.214M |
| Perspective Therapeutics Inc | -0.089M |
| Protalix BioTherapeutics Inc | -0.342M |
| Electromed Inc | -0.087M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.8509M |